laboratory specialized in the treatment of rare neurological diseases

« Rare neurological disorders, a major societal challenge and a market in crucial need of therapeutic innovation »

> Governance

Mathieu CHARVÉRIAT - CEO
Mathieu CHARVÉRIAT
CEO & co-founder